# Glucose Tolerance Study

> **NCT07412730** · PHASE2 · COMPLETED · sponsor: **RDC Clinical Pty Ltd** · enrollment: 19 (actual)

## Conditions studied

- Healthy Volunteers
- Glucose Tolerance

## Interventions

- **DIETARY_SUPPLEMENT:** TRPTI 150mg
- **DIETARY_SUPPLEMENT:** TRPTI 300mg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07412730
- **Lead sponsor:** RDC Clinical Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-03-11
- **Primary completion:** 2026-04-02
- **Final completion:** 2026-04-02
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2026-04-28

## Collaborators

- Gencor Pacific Limited, Hong Kong

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07412730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07412730, "Glucose Tolerance Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07412730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*